Upstream Bio revenue was $2.80M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $683.0k, down 27.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, UPB annual revenue was $2.4M, with -0.4% growth year-over-year.
UPB past revenue growth
How has UPB's revenue growth performed historically?
On Invalid Date, Upstream Bio (NASDAQ: UPB) reported Q3 2025 revenue of $683.00 thousand up 12.52% year over year. In the same quarter last year, Upstream Bio's revenue was $607.00 thousand.
What was Upstream Bio's revenue in 2024?
Upstream Bio's annual revenue for the twelve months ending Dec 31, 2024 was $2.37 million, a 0.42% decrease year over year.
How much does Upstream Bio make in a day?
Based on Upstream Bio annual revenue for the past two years, UPB makes an average of $6,506.85 per day.
What was Upstream Bio's annual revenue growth in the past year?
As of Q4 2025, Upstream Bio's revenue has grown 26.82% year over year. This is 272.75 percentage points lower than the US Biotechnology industry revenue growth rate of 299.57%. Upstream Bio's revenue in the past year totaled $2.80 million.
How much does Upstream Bio make in a year?
Upstream Bio's revenue by year for the past two years is:
Upstream Bio's revenue for the twelve months ending Dec 31, 2024 was $2.37 million, a 0.42% decrease year over year.
Upstream Bio's annual revenue for Dec 31, 2023 was $2.38 million, a 96.37% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.